newsfilter
← Latest News
PR Newswire·

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform

Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to...